Press Release 02 July 2025 White & Case advises Neopharmed Gentili on acquisition of ORLADEYO®’s European business from BioCryst Pharmaceuticals
Press Release 03 March 2025 White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics
Press Release 24 May 2024 White & Case advises Merck KGaA on agreement to acquire life science company Mirus Bio for US$600 million
Press Release 27 November 2023 White & Case Advises Athyrium Capital Management on the Restructuring of RevitaLid Pharmaceutical Corp. and its Subsidiaries
Press Release 02 October 2023 White & Case advises Azurity Pharmaceuticals, Inc. on acquisition of Slayback Pharma, LLC
Press Release 18 April 2023 White & Case Advises Graf Acquisition Corp. IV on Business Combination with NkGen Biotech, Inc.
Press Release 01 February 2023 White & Case Advises Biosynex on Merger Agreement With Chembio Diagnostics, Inc.
Press Release 10 November 2022 White & Case Advises Famy Life Sciences on Its Acquisition by Viatris Inc.
Press Release 14 September 2022 White & Case advises Apollomics Inc. on its US$899 million business combination with Maxpro Capital Acquisition Corp.
Press Release 18 May 2022 White & Case advises LOTTE Corporation on US$160 million acquisition of pharmaceutical manufacturing facility from Bristol Myers Squibb
Press Release 06 May 2022 White & Case Advises ADVANZ PHARMA on Acquisition of Intercept Pharmaceuticals
Press Release 12 May 2021 White & Case Advises Soaring Eagle Acquisition Corp. on Its Business Combination with Ginkgo Bioworks
Press Release 23 December 2020 White & Case Advises Takeda on Agreement to Divest Select Non-Core Assets to Hasten for Approximately US$322 Million
Press Release 11 September 2020 White & Case Advises Takeda on Agreement to Divest Select Non-core European Assets to Cheplapharm for Approximately US$562 Million
